Stepwise Evaluation of Plasmid‐ and Adeno‐Associated Virus‐Based Knock‐In Using A Triple‐Reporter Platform
Genes to Cells · 2026
DOI: 10.1111/gtc.70129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2026. Verfasst von Hiromasa Hara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. Hauptthemen laut MEDLINE: Dependovirus, Gene Knock-In Techniques, Plasmids, Recombinational DNA Repair. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development, Sumitomo Pharma Co. Ltd.
Abstract (Originalsprache)
Homology‐directed repair (HDR)‐mediated knock‐in efficiency is a composite of double‐strand break (DSB) induction and repair pathway selection during targeted insertion. Thus, optimization of HDR‐mediated knock‐in presents significant challenges. To address this, we employed a mouse embryonic stem cell‐based triple‐reporter platform to examine how donor design and experimental parameters are associated with DSB induction and the balance between HDR‐mediated knock‐in and end‐joining‐mediated targeted insertion (EJ‐TI). Our analysis reveals that donor design directly impacts DSB induction: co‐electroporation of donor plasmids with Cas9/gRNA reduced cleavage efficiency, and Homology‐Independent Targeted Integration (HITI) sequences further reduced this efficiency, thereby biasing overall knock‐in efficiency. When normalized to DSB levels, HITI increased total targeted insertion yield (knock‐in + EJ‐TI) with shorter arms and favored HDR‐mediated knock‐in over EJ‐TI with longer arms. Conversely, under adeno‐associated virus (AAV) donor conditions, HITI showed donor‐format dependency. It increased knock‐in and decreased EJ‐TI only with a self‐complementary AAV donor, but had little effect with a single‐stranded AAV donor. These results highlight the importance of separately evaluating DSB induction, total targeted insertion yield, and the balance between HDR‐mediated knock‐in and EJ‐TI using a triple‐reporter platform when optimizing knock‐in strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Laboratory of Regenerative and Cellular Medicine, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Division of Animal Resource Development, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Center for Experimental Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Translational Research Laboratory, Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Division of Functional Biochemistry, Department of Biochemistry, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
ORCID-Profile: Hiromasa Hara
Förderung
- Japan Agency for Medical Research and Development
- Sumitomo Pharma Co. Ltd
Zitieren
APA
Hara, H., Uosaki, H., Nakahara, F., Inoue, M., & Hanazono, Y. (2026). Stepwise Evaluation of Plasmid‐ and Adeno‐Associated Virus‐Based Knock‐In Using A Triple‐Reporter Platform. Genes to Cells. https://doi.org/10.1111/gtc.70129
Vancouver
Hara H, Uosaki H, Nakahara F, Inoue M, Hanazono Y. Stepwise Evaluation of Plasmid‐ and Adeno‐Associated Virus‐Based Knock‐In Using A Triple‐Reporter Platform. Genes to Cells. 2026. doi:10.1111/gtc.70129
BibTeX
@article{Hara2026,
author = {Hara, Hiromasa and Uosaki, Hideki and Nakahara, Fumio and Inoue, Makoto and Hanazono, Yutaka},
title = {Stepwise Evaluation of Plasmid‐ and Adeno‐Associated Virus‐Based Knock‐In Using A Triple‐Reporter Platform},
journal = {Genes to Cells},
year = {2026},
doi = {10.1111/gtc.70129}
}
EUVIMED